Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TLT vs MRNA✓SelectedUSD · MRNATLT vs MRNA performance historyLatest closeAs of0.00%11/16
Stock and ETF performance explorer

TLT vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-15.2%
MRNA return
+878.5%
Excess return
-893.7%
Maximum drawdown
-48.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D0.0%-3.6%+3.6%0.0%
7D-3.1%-20.0%+16.8%-2.9%
30D-0.4%-1.3%+0.8%-0.5%
3M-2.1%+240.0%-242.0%-4.9%
6M-2.8%+339.0%-341.8%-6.1%
YTD-5.4%+630.0%-635.3%-9.4%
1Y-6.5%+769.1%-775.6%-10.8%
3Y+0.7%+181.2%-180.5%-2.6%
5Y-34.4%-8.1%-26.3%-35.9%
All-15.2%+878.5%-893.7%-17.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling